6월 30 게시
These firms earn massive fees on every billion-dollar deal. With global M&A values rising over 15%, they're positioned at the center of a potential revenue windfall.
Corporate confidence is driving larger, higher-value transactions, especially in resilient sectors like technology and healthcare. These are the companies orchestrating those headline-making deals.
Beyond the giant investment banks, this collection includes specialized advisory firms and private equity players that often fly under the radar while profiting enormously from the dealmaking surge.
Wall Street is seeing a resurgence in high-value mergers and acquisitions, especially in technology and healthcare. This collection focuses on the financial institutions that facilitate these deals and earn substantial fees from this activity, positioning them to benefit directly from continued corporate confidence.
These companies represent different aspects of the dealmaking ecosystem – from elite investment banks and independent advisory firms to private equity giants. They generate revenue through advisory fees, financing interest, and transaction services as global deal values climb by over 15%.
This selection includes premier names like Goldman Sachs and specialized firms like Evercore that directly profit from increased M&A activity. These companies are strategically positioned at the center of corporate transactions, making them potential beneficiaries of this cyclical boom in dealmaking.
Market capitalisation breakdown for the basket named 'The Dealmakers: M&A Boom'.
GS: $229.76B
EVR: $13.11B
JPM: $816.92B
이 바스켓의 전체 스토리를 확인하세요. 리스크와 잠재력을 다룬 상세 기사를 읽어보세요.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
Earn 6% AER on uninvested cash with daily interest payments.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
GS
GS
현재가
$1,029.10
As a top-tier global investment bank, Goldman Sachs is a primary beneficiary of increased M&A activity, earning significant fees from its advisory ser...
As a top-tier global investment bank, Goldman Sachs is a primary beneficiary of increased M&A activity, earning significant fees from its advisory services on major transactions.
JPMorgan Chase & Co
JPM
현재가
$356.28
JPMorgan's extensive investment banking division is perfectly positioned to capitalize on the M&A surge through both advisory roles and providing deal...
JPMorgan's extensive investment banking division is perfectly positioned to capitalize on the M&A surge through both advisory roles and providing deal financing.
Join Nemo FREE today and unlock every stock.
60초면 충분합니다.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
이 자산들에 투자했다면:
12개월 후 예상 가치:
+3.31%
애널리스트들은 이 그룹의 자산이 향후 1년간 평균 3.31% 성장할 것으로 예상합니다.
이 그룹의 자산 15개 중 10개가 전문 애널리스트로부터 매수 의견을 받았습니다.
